Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent trends in allogeneic bone marrow transplantation.

E Gluckman1

  • 1Unité Fontionelle de Greffe de Moelle, Paris, France.

Cancer Detection and Prevention
|January 1, 1990
PubMed
Summary

Allogeneic bone marrow transplants offer varying survival rates for leukemias and chronic myeloid leukemia, influenced by factors like age and donor match. Ongoing research aims to improve outcomes by reducing relapse and graft-versus-host disease risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

Bone marrow transplantation·2007
Same author

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.

Bone marrow transplantation·2007
Same author

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·2007
Same author

[Clinical research at the European LeukemiaNet].

Deutsche medizinische Wochenschrift (1946)·2006

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a recognized treatment for hematologic malignancies.
  • Registry data provides insights into the outcomes of BMT across different disease types and patient populations.

Purpose of the Study:

  • To summarize the established indications and outcomes of allogeneic bone marrow transplantation based on registry analyses.
  • To highlight current research directions aimed at improving BMT efficacy and safety.

Main Methods:

  • Analysis of European and International bone marrow transplantation registries.
  • Review of disease-free survival (DFS) and relapse risk (RR) data for various leukemias and chronic myeloid leukemia (CML).
  • Consideration of risk factors influencing transplant outcomes, including patient and donor characteristics.

Main Results:

  • Disease-free survival (DFS) rates vary: 45% for acute non-lymphoblastic leukemia (ANLL) in first CR, 60% for acute lymphoblastic leukemia (ALL) in first CR, 40% for ALL in second CR, and 60% for CML in chronic phase.
  • Relapse risks (RR) range from 15% for ANLL and ALL in first CR to 30% for ALL in second CR and 20% for CML.
  • Mismatched related donor transplants show limited success, except with one HLA mismatch. Unrelated HLA matched donor transplants yield approximately 40% DFS.

Conclusions:

  • Allogeneic BMT outcomes are influenced by disease type, remission status, and donor matching.
  • Further research is focused on mitigating risks such as relapse and graft-versus-host disease (GVHD), and enhancing engraftment.
  • Investigating alternative donor sources and therapeutic strategies is crucial for advancing allogeneic BMT.

Related Experiment Videos